معرفی
Dr. Swati Kulkarni is a Professor of Surgery in the Department of Surgery (Breast Surgery) at Northwestern University Feinberg School of Medicine, specializing in breast surgical oncology and translational research. Board-certified by the American Board of Surgery, she leads clinical trials focused on breast cancer prevention and treatment innovation while serving on national committees including the National Comprehensive Cancer Network Breast Cancer Screening Panel.
Her educational background includes:
- MD from Medical College of Pennsylvania (1995)
- General Surgery Residency at New York Presbyterian Hospital, Weill Cornell Medical College
- Breast Surgical Oncology Fellowship at Northwestern University
Dr. Kulkarni's research centers on obesity-breast cancer risk relationships, tamoxifen resistance mechanisms, and novel therapeutic agents. She directs NCI-funded trials including a Phase II study of tissue-selective estrogen complexes for DCIS prevention and the VIVID trial evaluating 3D imaging for margin assessment during breast conservation surgery, bridging laboratory discoveries with clinical applications.
Her recent publications demonstrate consistent focus on surgical innovation in breast oncology, with emphasis on technological solutions for margin control, understanding barriers to clinical trial participation, and specialized care scenarios like lactation during breast cancer treatment. This work advances precision approaches in surgical oncology through engineering integration and patient-centered methodology.
Among numerous accolades, she has received:
- Multiple Excellence in Medical Student Teaching awards from Feinberg School of Medicine (2016-2021)
- Society of University Surgeons Travel Award (2018)
- Best Doctors in America recognition (2011)
- NRSA Surgical Oncology Research Fellowships
Dr. Kulkarni mentors medical students and residents through structured clinical education programs, evidenced by repeated teaching awards. Her current NCI-funded VIVID trial (NU 21B01) investigates volumetric specimen imaging to minimize re-excision rates in breast conservation surgery, representing significant translational research investment.
She maintains active leadership within the Robert H. Lurie Comprehensive Cancer Center and serves on editorial boards including Annals of Surgical Oncology, driving advancements in breast cancer research through multidisciplinary collaboration and national guideline development.
